Business Context and Reporting Period
This Form 8-K filing by Fluidigm Corporation (noted as Standard BioTools Inc. in metadata) covers the 2018 Annual Meeting of Stockholders held on May 31, 2018. The report details the voting outcomes for director elections, executive compensation, and the ratification of the independent auditor.
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder voting results.
Material Changes and Voting Results
- Shareholder Participation: Approximately 91.77% of outstanding shares (35,711,530 of 38,912,978) were represented at the meeting.
- Director Elections: Nominees Gerhard F. Burbach and Carlos Paya were elected as Class II directors.
- Executive Compensation (Say-on-Pay): A majority of stockholders voted against the advisory approval of executive compensation for the year ended December 31, 2017.
- Votes For: 15,370,953
- Votes Against: 15,887,229
- Auditor Ratification: PricewaterhouseCoopers LLP was ratified as the independent registered public accounting firm with overwhelming support (35,685,008 votes for).
Management Commentary and Outlook
Management acknowledged the negative vote on executive compensation but maintains that current compensation is aligned with company performance. Key points from the company statement include:
- Alignment Strategy: The company is focused on value creation and will continue active engagement with stockholders.
- Compensation Structure: Executive compensation historically includes stock options that generate value only through stock price appreciation.
- Recent Actions:
- Instituted Stock Ownership Guidelines for non-employee directors and senior executives.
- Granted performance-based restricted stock units (PRSUs) in 2018, accounting for 25% of target award value, tied to pre-established financial performance criteria.
- Future Plans: The company intends to explore further enhancements to performance-based compensation programs, with details to be provided in the 2019 proxy statement.
Investor Verification Checklist
- Verify the specific reasons cited by dissenting shareholders for the "Say-on-Pay" vote against management.
- Review the 2018 Proxy Statement for detailed breakdowns of executive compensation packages.
- Monitor the 2019 Proxy Statement for updates on the implementation of new performance-based compensation metrics.
- Confirm the specific financial performance criteria attached to the 2018 PRSU awards.